Correction: A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) [Oncotarget, 8, (2017) (15943-15951)] DOI: 10.18632/oncotarget.13056

Hye Ryun Kim, Joung Soon Jang, Jong Mu Sun, Myung Ju Ahn, Dong Wan Kim, Inkyung Jung, Ki Hyeong Lee, Joo Hang Kim, Dae Ho Lee, Sang We Kim, Byoung Chul Cho

Research output: Contribution to journalComment/debate

Abstract

Present: The current funding information is incomplete. Correct: The complete funding information is given below.

Original languageEnglish
Number of pages1
JournalOncotarget
Volume8
Issue number33
DOIs
Publication statusPublished - 2017 Jan 1

All Science Journal Classification (ASJC) codes

  • Oncology

Fingerprint Dive into the research topics of 'Correction: A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) [Oncotarget, 8, (2017) (15943-15951)] DOI: 10.18632/oncotarget.13056'. Together they form a unique fingerprint.

  • Cite this